Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6023

A trio of biotechs target $250M offerings; Regeneron stops cell therapy trial

$
0
0
Plus, news about AbbVie, Novartis, Analytical Biosciences, ENA Respiratory, VitriVax, Galera and Gilead: 👁️ Viridian Therapeutics launches $251M offering: The biotech is selling 11.4 million shares at $22.00 apiece. It plans ...

Viewing all articles
Browse latest Browse all 6023

Trending Articles